9.Keto Asidosis Diabetik

Embed Size (px)

Citation preview

  • 7/29/2019 9.Keto Asidosis Diabetik

    1/30

    Keto-Asidosis Diabetik

    Pradana Soewondo

    Division of Endocrinology and Metabolism,Department of Medicine, School of Medicine

    University of Indonesia

  • 7/29/2019 9.Keto Asidosis Diabetik

    2/30

    Diabetic Complications

    Diabetic Ketoacidosis = DKA

    Hyperosmolar Hyperglycemia

    Nonketoric Coma = HHNC

    RetinopathyNephropathy

    Neuropathy

    Macroangiopathy

    Chronic :Acute :

    Microangiopathy

    CADPVD

    Stroke

    Hypoglycemia

    Metabolic Decompensation

  • 7/29/2019 9.Keto Asidosis Diabetik

    3/30

    Hyper-

    glycemia Acidosis

    Ketosis

    DKA

    Kitabchi and Wall

    Hyperglycemia statesDM

    HHNC

    IGT

    Stress

    Metabolic Acidosis statesLactic acidosis

    Hyperchloremic acidosis

    Salicylism

    Uremic acidosis

    Drug-inducedacidosis

    Ketotic statesKetotic hypoglycemia

    Alkaholic ketotis

    Starvation ketosis

  • 7/29/2019 9.Keto Asidosis Diabetik

    4/30

    DKA Episode and Mortality Rate at Dr. CiptoMangunkusumo Hospital, Jakarta

    Year Number of Cases Mortality rate %

    1983-84 (9 months) 14 31,4

    1984-88 (48 months) 55 40

    1995 (12 months) 17 -

    1997 (6 months) 23 18,7

    1998-99 (12 months) 37 51

    2002 (5 months) 39 15

  • 7/29/2019 9.Keto Asidosis Diabetik

    5/30

    DKA HHNC

    DKA HHNC

  • 7/29/2019 9.Keto Asidosis Diabetik

    6/30

    PATOGENESISKAD

  • 7/29/2019 9.Keto Asidosis Diabetik

    7/30

    LIPOLYSIS

    A C E T O A C E T A T E

    FATTY ACYL CoA

    A C E T O N E3- H Y D R O X YB U T Y R A T E

    MITOCHONDRION

    K E T O N B O D I E S

    HEPATOCYTE

    CYTOSOL

    FFA

    Catecholamine

    Growth Hormone

    Insulin

    SHUTTL

    E

    Insulin

    FATTY ACYL CoA

    Glucagon

    FATTY ACYL CoA

    CoA

    KETOGEN

    ESIS

  • 7/29/2019 9.Keto Asidosis Diabetik

    8/30

    Triglyceride

    Malonyl CoA

    CPT 1Carnitine

    Acyl Co A

    Glycerol-3-P

    Glucagon

    Acetyl CoA

    Insulin

    Acetyl CoA

    Acyl carnitine

    Acyl carnitine

    3 Hydroxybuyrate

    3-HMG CoA

    Acetoacetyl CoAAcyl Co A

    Acetoacetate

    CarnitineCPT 2

    Acetone

    b oxidat ion

    +

    --outer

    inner

    mitochondrial

    membrane

    Krebs

    cycle

    CYTOSOL

    MITOCHON-DRION

    Fatty acid

  • 7/29/2019 9.Keto Asidosis Diabetik

    9/30

    DKA HHNC

    Kadar Hormon dan FFA pada KAD

  • 7/29/2019 9.Keto Asidosis Diabetik

    10/30

    Clinical Features of DKA

    Abdominal pain

    Leg cramps

    Nausea and vomiting

    Confusion and

    drowsiness

    Coma

    Polyuria and nocturia

    Weight loss

    Weakness

    Blurred vision

    Kussmaul respiration

  • 7/29/2019 9.Keto Asidosis Diabetik

    11/30

    Precipitating Factors of DKA & HHNC

    Infection

    Cerebro vascular

    accident

    Pancreatitis

    Myocardial infarction

    Trauma

    Medication

    Newly type 1

    diabetes

    Discontinuation of or

    inadequate insulin

    Substance abuse

    Not found

  • 7/29/2019 9.Keto Asidosis Diabetik

    12/30

  • 7/29/2019 9.Keto Asidosis Diabetik

    13/30

    Average Water and Electrolyte Deficits in DKA

    Water (liters) 5 - 7 liters

    Sodium (mmol) 500

    Chloride (mmol) 350

    Potassium (mmol) 300 - 1000

    Calcium (mmol) 50 - 100

    Phosphate (mmol) 50 - 100

    Magnesium (mmol) 25 - 50

  • 7/29/2019 9.Keto Asidosis Diabetik

    14/30

    PrincipalManagement

    of DKAand HHNC

  • 7/29/2019 9.Keto Asidosis Diabetik

    15/30

    Hour Hydration Insulin K+Correction HCO3- correction

    0 guyur 50 mEq per If pH

    guyur six hour 7.1

    guyur Start hour 2iv bolus iv,

    Cont by infusion

    dst dst dst

    Management of DKAat Cipto Mangunkusumo Hospital, Jakarta

    A B C D E

    Lihat perincian pada slide berikut (per kolom)

  • 7/29/2019 9.Keto Asidosis Diabetik

    16/30

    Jam 0 2 kolf 1/2 jam1 1 kolf 1/2 jam Guyur dengan NaCl 0,9%2 1 kolf 1 jam3 1 kolf 2 jam4 dst. bergantung kebutuhan

    Sebaiknya dimonitor dengan CVP.

    Jumlah cairan per 15 jam sekitar 5 liter.

    Bila kadar Na+ > 155 mEq/L (osmolarity >350 mosm/L) gunakan1/2 n NaCl.

    Bila kadar glukose darah < 200 mg/dl NaCl diganti dextrose 5%.

    Rehidrasi B

  • 7/29/2019 9.Keto Asidosis Diabetik

    17/30

    Pemberian Insulin C

    Mulai jam ke 2 dengan bolus 180 mU/kg BB (7-10 U/jam) I.V

    dilanjutkan dengan drip 90mU/kgBB/jam dalam NaCl 0,9%(3 4 U/jam)

    Bila kadar gd < 200mg/dl kecepatan drip insulin dikurangisetengahnya menjadi 45mU/kg/jam (1,5 2 U/jam)

    Bila kadar gd stabil 200-300mg/dl, drip 1 U/jam + slidingscale tiap 6 jam:

    gd 350 mg/dl 20 unit

    Bila pasien sudah bisa makan dan gd stabil dengan sliding

    scale rutin 3 kali sehari dengan dosis tetap

  • 7/29/2019 9.Keto Asidosis Diabetik

    18/30

    Koreksi K+ D

    Pada jam 0 diberikan KCl 50 mEq per 6 jam dengan drip dalaminfusSetelah 6 jam di cek lagi kadar K+ Bila kadar K+ (mEq/L):

    < 3 3-4,5 4,5-6 >6

    75 50 25 0

    mEq/ mEq/ mEq/6 jam 6 jam 6 jam

    Bila sudah sadar, beri K+ per oral selama seminggu

  • 7/29/2019 9.Keto Asidosis Diabetik

    19/30

  • 7/29/2019 9.Keto Asidosis Diabetik

    20/30

  • 7/29/2019 9.Keto Asidosis Diabetik

    21/30

    The Benefit of 3HB Measurement within 24hours management of DKA at RSCM Jakarta

    Ika P, Soewondo P et al. RSCM, Jakarta 2001.

    OBJECTIVE To observe the benefit of 3HB in 24 hour management of

    DKA.

    To describe the changing of parameter metabolic variable

    during the first 24 hours in the management of DKA

    METHOD

    Hospital based, observational study, enrolliring DKA patients

    19 from 39 DKA patients participated in this study

    January-May 2002

  • 7/29/2019 9.Keto Asidosis Diabetik

    22/30

    Enrollement

    39 DKA patients

    20 excluded 19 included

    4 patients died

    within 24 hours

    15 patients

    completely of study

    Serial measurement of

    Blood glucose, BGA,

    AcAc, 3HB, Electrolyte

    every 6 hours

  • 7/29/2019 9.Keto Asidosis Diabetik

    23/30

    Measurements at presentation of DKA

    N 19

    Age (years) 48.16 12.51

    Sex (M/F) 8/11

    Blood Glucose 383 80.30

    Arterial pH 7.24 0.21

    Blood pCO2 18.87 7.19

    Blood

    bicarbonate

    10.17 6.37

    BUN 43.24 40.18

    Serum Creatinine 2.48

    Serum AcAc (+/-) +++ (Median)

    Blood 3HB (mmol/L) 3.31 2.41

    K + (mmol/L) 4.52 0.92

    Na + (mmol/L) 127.1 9.92

  • 7/29/2019 9.Keto Asidosis Diabetik

    24/30

    Changes of 3HB and AcAc in 24 hours

    Hours

    241812620

    3,5

    3,0

    2,5

    2,0

    1,5

    1,0

    ,5

    0,0

    3,0

    2,0

    1,0

    0,0

    3HB

    AcAc

  • 7/29/2019 9.Keto Asidosis Diabetik

    25/30

    7.3

    7.2 art. blood pH

    241812620

    25

    20

    15

    10

    5

    0

    Blood 3HB

    Serum AcAc

    pCO2

    HCO3

    Anion Gap

    BG (mmol/l)

    Observ

    asi24jam

    pH darah

    glucose

    pCO2

    HCO3

    3HB

  • 7/29/2019 9.Keto Asidosis Diabetik

    26/30

    0

    2

    6

    12

    18

    24

    Hour

    Correlation 3HB and Blood pH

    0.00 2.00 4.00 6.00

    3HB

    6.80

    7.00

    7.20

    7.40

    pH

  • 7/29/2019 9.Keto Asidosis Diabetik

    27/30

    0

    2

    6

    12

    18

    24

    Hour

    Correlation 3HB and Blood Bicarbonate

    0.00 2.00 4.00 6.00

    3HB

    5.00

    10.00

    15.00

    20.00

    25.00

    HCO3

  • 7/29/2019 9.Keto Asidosis Diabetik

    28/30

    0

    2

    6

    12

    18

    24

    Hour

    Correlation 3HB and Anion Gap

    0.00 2.00 4.00 6.00

    3HB

    0.00

    10.00

    20.00

    30.00

    Anion

    Gap

  • 7/29/2019 9.Keto Asidosis Diabetik

    29/30

    Kesimpulan

    KAD dan HHNK komplikasi akut DM dengan angka

    kesakitan dan kematian yang tinggi.

    Patogenesis KAD dan HHNK defisiensi insulin dan

    peningkatan kadar hormon kontraregulator insulin.

    Faktor pencetus utama Infeksi

    Pemeriksaan benda keton - 3HB secara bedsite dapat

    mempercepat diagnosis KAD bahkan dapat mencegah

    KAD pada pasien DM saat sakit/demam.

    Evaluasi 3HB serial membantu dalam pengelolaan

    KAD - peralihan terapi titerasi insulin ke dosis tetap.

  • 7/29/2019 9.Keto Asidosis Diabetik

    30/30